Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M M, van Gameren"'
Autor:
Pieter Limburg, M. M. Van Gameren, Edo Vellenga, E. G. E. de Vries, Harry J.M. Groen, Phb Willemse, Nh Mulder
Publikováno v:
Blood. 84:1434-1441
To define the toxicity profile of recombinant human interleukin-6 (rhIL- 6) and to study its effect on hematopoiesis, biochemical parameters and other cytokines, rhIL-6 was administered in a phase I-II study to 20 patients with breast carcinoma or no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae5ab711ce8faed27986ad69e5a19785
https://doi.org/10.1182/blood.v84.5.1434.1434
https://doi.org/10.1182/blood.v84.5.1434.1434
Autor:
M M, van Gameren, P H, Willemse, N H, Mulder, P C, Limburg, H J, Groen, E, Vellenga, E G, de Vries
Publikováno v:
Blood. 84:1434-1441
To define the toxicity profile of recombinant human interleukin-6 (rhIL- 6) and to study its effect on hematopoiesis, biochemical parameters and other cytokines, rhIL-6 was administered in a phase I-II study to 20 patients with breast carcinoma or no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d203ae8207e991f342bc4f87463097
https://doi.org/10.1182/blood.v84.5.1434.bloodjournal8451434
https://doi.org/10.1182/blood.v84.5.1434.bloodjournal8451434
Autor:
J.G. Aalders, Nh Mulder, Bonne Biesma, E.G.E. de Vries, Phb Willemse, B. Mull, G. J. Veldhuis, M. M. Van Gameren
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 13(3)
PURPOSE To define the optimal dose of recombinant human interleukin-3 (rhIL-3) required to intensify the dose of carboplatin and cyclophosphamide for advanced epithelial ovarian cancer. PATIENTS AND METHODS Seventeen patients were treated on day 1 wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186af247f5f509d3499a540f65885ad6
https://pubmed.ncbi.nlm.nih.gov/7884433
https://pubmed.ncbi.nlm.nih.gov/7884433
Publikováno v:
Stem cells (Dayton, Ohio). 11(2)
Interleukin 3 (IL-3) is a multipotent hematopoietic growth factor which became available as a recombinant (rh) growth factor for use in the clinic a few years ago. In dose-finding studies, this hematopoietic growth factor has been evaluated without a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd769f183c1d2771547ee109b3057599
https://pubmed.ncbi.nlm.nih.gov/8457787
https://pubmed.ncbi.nlm.nih.gov/8457787
Autor:
Harry J.M. Groen, M. M. Van Gameren, Joachim Widder, Henk P. Bijl, A. H. D. Van Der Leest, Jan F. Ubbels, Johannes A. Langendijk, G. Wester
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 69:S480
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea7f6e5c29f8518ef6e1ad367bc53154
https://doi.org/10.1016/j.ijrobp.2007.07.1681
https://doi.org/10.1016/j.ijrobp.2007.07.1681
Autor:
van Gameren M; Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam 1081 BT, the Netherlands., Voorn PB; Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam 1081 BT, the Netherlands; Faculty of Health, Centre of Expertise Urban Vitality, Amsterdam University of Applied Sciences, Amsterdam, Tafelbergweg 51, Amsterdam 1105 BD, the Netherlands., Bossen D; Faculty of Health, Centre of Expertise Urban Vitality, Amsterdam University of Applied Sciences, Amsterdam, Tafelbergweg 51, Amsterdam 1105 BD, the Netherlands., Hoozemans MJM; Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam 1081 BT, the Netherlands., Bruijn SM; Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam 1081 BT, the Netherlands., Bosmans JE; Department of Health Sciences, Faculty of Science, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam 1081 BT, the Netherlands., Visser B; Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam 1081 BT, the Netherlands; Faculty of Health, Centre of Expertise Urban Vitality, Amsterdam University of Applied Sciences, Amsterdam, Tafelbergweg 51, Amsterdam 1105 BD, the Netherlands., Pijnappels M; Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam 1081 BT, the Netherlands. Electronic address: m.pijnappels@vu.nl.
Publikováno v:
Gait & posture [Gait Posture] 2024 Oct; Vol. 114, pp. 78-83. Date of Electronic Publication: 2024 Sep 10.
Autor:
van Gameren M; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands., Lemmert ME; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands., Wilschut JM; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands., Daemen J; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands., De Jaegere PPT; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands., Zijlstra F; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands., Van Mieghem NMDA; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands., Diletti R; a Department of Cardiology , Thoraxcenter, Erasmus University Medical Center , Rotterdam , The Netherlands.
Publikováno v:
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2018 Sep; Vol. 19 (13), pp. 1441-1450. Date of Electronic Publication: 2018 Sep 05.
Autor:
VAN GAMEREN M; Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands. m.vangameren@erasmusmc.nl, KLIEVERIK LM, STRUIJS A, VENEMA AC, KAPPETEIN AP, BOGERS AJ, TAKKENBERG JJ
Publikováno v:
The Journal of cardiovascular surgery [J Cardiovasc Surg (Torino)] 2009 Oct; Vol. 50 (5), pp. 703-9.